Similarly, in hepatocytes, cGAS-STING signaling drives inflammation, lipid accumulation, and fibrosis, contributing to the progression of NAFLD and NASH. The gene discussed is CGAS; the disease is metabolic dysfunction-associated steatotic liver disease.